Cspc Pharmaceutical Group

(OTC) CHJTF

Current Price$1.05

Market Cap$12.03B

Since IPO (2003)+209%

5 Year+13%

1 Year+70%

1 Month+3%

Cspc Pharmaceutical Group Financials at a Glance

Market Cap

$12.03B

Revenue (TTM)

$46.62B

Net Income (TTM)

$6.41B

EPS (TTM)

$0.05

P/E Ratio

22.29

Dividend

$0.03

Beta (Volatility)

0.03 (Low)

Dividend

$0.03

Beta (Volatility)

0.03 (Low)

Price

$1.05

Volume

2,000

Open

$1.05

Price

$1.05

Volume

2,000

Open

$1.05

Previous Close

$1.05

Daily Range

$1.05 - $1.05

52-Week Range

$0.64 - $1.39

Dividend

$0.03

Beta (Volatility)

0.03 (Low)

Price

$1.05

Volume

2,000

Open

$1.05

Previous Close

$1.05

Daily Range

$1.05 - $1.05

52-Week Range

$0.64 - $1.39

CHJTF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cspc Pharmaceutical Group

Industry

Pharmaceuticals

Sector

Health Care

Employees

19,700

CEO

Lei Cai, PhD

Website

www.cspc.com.hk

Headquarters

Shijiazhuang, 050035, CN

CHJTF Financials

Key Financial Metrics (TTM)

Gross Margin

66%

Operating Margin

15%

Net Income Margin

15%

Return on Equity

12%

Return on Capital

11%

Return on Assets

Earnings Yield

4.49%

Dividend Yield

2.92%

Payout Ratio

65.13%

Stock Overview

Market Cap

$12.03B

Shares Outstanding

11.46B

Volume

2.00K

Avg. Volume

917.857

Financials (TTM)

Gross Profit

$18.50B

Operating Income

$4.31B

EBITDA

$5.83B

Operating Cash Flow

$6.56B

Capital Expenditure

$2.13B

Free Cash Flow

$4.44B

Cash & ST Invst.

$9.87B

Total Debt

$713.91M

Cspc Pharmaceutical Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$13.94B

+83.7%

Gross Profit

$9.14B

-51.1%

Gross Margin

65.57%

N/A

Market Cap

$12.03B

N/A

Market Cap/Employee

$562.20K

N/A

Employees

21,400

N/A

Net Income

$1.46B

+5.9%

EBITDA

$2.32B

+29.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$9.16B

-26.1%

Accounts Receivable

$10.63B

+5.0%

Inventory

$3.44B

-0.3%

Long Term Debt

$201.21M

+87.9%

Short Term Debt

$512.70M

-14.5%

Return on Assets

8.07%

N/A

Return on Invested Capital

10.56%

N/A

Free Cash Flow

$2.22B

+13.5%

Operating Cash Flow

$3.08B

-2.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ERFSFEurofins Scientific SE

ERFSFEurofins Scientific SE$70.95+5.16%

RCDTFRecordati Industria Chimica e Farmaceutica S.p.A.

RCDTFRecordati Industria Chimica e Farmaceutica S.p.A.$55.88+0.00%

ALBBYAlibaba Health Information Technology Limited

ALBBYAlibaba Health Information Technology Limited$11.15-7.47%

BIOVFSwedish Orphan Biovitrum AB (publ)

BIOVFSwedish Orphan Biovitrum AB (publ)$47.35+9.73%

SGIOYShionogi & Co., Ltd.

SGIOYShionogi & Co., Ltd.$9.86-2.28%

GIFLFGrifols, S.A.

GIFLFGrifols, S.A.$10.57+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

FFord Motor Company

FFord Motor Company$11.88-0.02%

MARAMara Holdings

MARAMara Holdings$11.46-0.04%

Questions About CHJTF

What is the current price of Cspc Pharmaceutical Group?

Cspc Pharmaceutical Group is trading at $1.05 per share.

What is the 52-week range for Cspc Pharmaceutical Group?

Over the past 52 weeks, Cspc Pharmaceutical Group has traded between $0.64 and $1.39.

How much debt does Cspc Pharmaceutical Group have?

As of the most recent reporting period, Cspc Pharmaceutical Group reported total debt of $91.74M.

How much cash does Cspc Pharmaceutical Group have on hand?

Cspc Pharmaceutical Group reported $754.52M in cash and cash equivalents in its most recent financial results.

What is Cspc Pharmaceutical Group’s dividend yield?

Cspc Pharmaceutical Group currently has a dividend yield of 2.92%.

Cspc Pharmaceutical Group

Cspc Pharmaceutical Group Financials at a Glance

CHJTF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cspc Pharmaceutical Group

CHJTF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cspc Pharmaceutical Group Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CHJTF

What is the current price of Cspc Pharmaceutical Group?

What is the 52-week range for Cspc Pharmaceutical Group?

How much debt does Cspc Pharmaceutical Group have?

How much cash does Cspc Pharmaceutical Group have on hand?

What is Cspc Pharmaceutical Group’s dividend yield?

Premium Investing Services